NDC00300-3626-28: LEUPROLIDE ACETATE INJECTION KIT.
LEUPROLIDE ACETATE INJECTION KIT. Key specifications include usage_design: FOR USE IN THE TREATMENT OF PROSTATIC CANCER, special_features: STERILE; AQUEOUS SOLUTION; 5 MG. LEUPROLIDE ACETATE PER ML., protective_storage_feature: ANTINEOPLASTIC DRUG AND REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS AND SUBJECT TO DAMAGE BY FREEZING.
This part is cataloged in the U.S. Government catalog under NSN 6505-01-363-0935, indicating validated use in U.S. government and defense logistics supply chains.
Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels. Verify compatibility with your specific system configuration before ordering.
| usage_design | FOR USE IN THE TREATMENT OF PROSTATIC CANCER |
| special_features | STERILE; AQUEOUS SOLUTION; 5 MG. LEUPROLIDE ACETATE PER ML. |
| protective_storage_feature | ANTINEOPLASTIC DRUG AND REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS AND SUBJECT TO DAMAGE BY FREEZING |
| NSN | 6505-01-363-0935 |
| SPECIAL FEATURES | STERILE; AQUEOUS SOLUTION; 5 MG. LEUPROLIDE ACETATE PER ML. |
| PROTECTIVE STORAGE FEATURE | ANTINEOPLASTIC DRUG AND REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS AND SUBJECT TO DAMAGE BY FREEZING |
| USAGE DESIGN | FOR USE IN THE TREATMENT OF PROSTATIC CANCER |